IRON vs REGN: Which Stock is Better?
Side-by-side comparison of Disc Medicine Inc and Regeneron Pharmaceuticals Inc in 2026
IRON
Disc Medicine Inc
$70.18
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | IRON | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.69B | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze IRON
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRON or REGN a better investment?
Comparing IRON and REGN: Disc Medicine Inc has a market cap of $2.69B while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRON and REGN?
IRON (Disc Medicine Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRON or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRON or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for IRON.
Which company is more profitable: IRON or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for IRON.
Which is the larger company: IRON or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $2.69B for IRON.
Should I buy IRON or REGN in 2026?
Both IRON and REGN have investment merit. IRON trades at $70.18 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRON and REGN stock?
Key differences: Market Cap ($2.69B vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).